Janet M. Pavese, Ph.D.

Affiliations: 
2014 Life Sciences Northwestern University, Evanston, IL 
Area:
Oncology
Google:
"Janet Pavese"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Raymond C. Bergan grad student 2014 Northwestern
 (Mitogen-Activated Protein Kinase Kinase 4 (MEK4) Promotes Human Prostate Cancer Invasion and Metastasis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xu L, Gordon R, Farmer R, et al. (2018) Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454
Pavese JM, Ogden IM, Voll EA, et al. (2014) Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289
Pavese JM, Bergan RC. (2014) Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352: 179-86
Pavese JM, Krishna SN, Bergan RC. (2014) Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. The American Journal of Clinical Nutrition. 100: 431S-6S
Voll EA, Ogden IM, Pavese JM, et al. (2014) Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63
Pavese J, Ogden IM, Bergan RC. (2013) An orthotopic murine model of human prostate cancer metastasis. Journal of Visualized Experiments : Jove. e50873
Xu L, Farmer R, Huang X, et al. (2012) Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752
Pavese JM, Ogden I, Huang X, et al. (2012) Abstract 3277: Increased mitogen-activated protein kinase kinase 4 (MEK4) induces metastasis in an orthotopic murine model of prostate cancer Cancer Research. 72: 3277-3277
Pavese JM, Ogden IM, Huang X, et al. (2011) Abstract 1407: Mitogen-activated protein kinase kinase 4 (MEK4) is a key regulator of prostate cancer progression Cancer Research. 71: 1407-1407
Xu L, Farmer R, Huang X, et al. (2011) Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10
See more...